| Title |
Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study
|
|---|---|
| Published in |
Cancer Immunology, Immunotherapy, April 2007
|
| DOI | 10.1007/s00262-007-0310-7 |
| Pubmed ID | |
| Authors |
Martin Sebastian, Bernward Passlick, Hilke Friccius-Quecke, Michael Jäger, Horst Lindhofer, Frank Kanniess, Rainer Wiewrodt, Eckhard Thiel, Roland Buhl, Alexander Schmittel |
Mendeley readers
The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Austria | 1 | <1% |
| Unknown | 103 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 14% |
| Student > Bachelor | 7 | 7% |
| Other | 6 | 6% |
| Student > Master | 6 | 6% |
| Student > Ph. D. Student | 6 | 6% |
| Other | 7 | 7% |
| Unknown | 57 | 55% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 18 | 17% |
| Biochemistry, Genetics and Molecular Biology | 9 | 9% |
| Agricultural and Biological Sciences | 7 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
| Immunology and Microbiology | 3 | 3% |
| Other | 2 | 2% |
| Unknown | 61 | 59% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 January 2024.
All research outputs
#1,516,230
of 23,153,849 outputs
Outputs from Cancer Immunology, Immunotherapy
#44
of 2,903 outputs
Outputs of similar age
#3,084
of 76,837 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#1
of 20 outputs
Altmetric has tracked 23,153,849 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,903 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 76,837 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.